Juan Andres
Director/Board Member at AVANTOR, INC.
Net worth: 1 M $ as of 2024-03-30
Juan Andres active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AVANTOR, INC. | Director/Board Member | 2019-08-31 | - |
| Independent Dir/Board Member | 2019-08-31 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Career history of Juan Andres
Former positions of Juan Andres
| Companies | Position | Start | End |
|---|---|---|---|
| EVELO BIOSCIENCES, INC. | Director/Board Member | 2019-12-03 | 2023-11-19 |
| Independent Dir/Board Member | 2019-12-03 | 2023-11-19 | |
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 2017-07-31 | 2022-12-31 |
| Corporate Officer/Principal | 2022-12-31 | 2023-05-30 | |
| NOVARTIS AG | Chief Tech/Sci/R&D Officer | 2005-07-31 | 2017-05-31 |
| Corporate Officer/Principal | - | - | |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 1986-12-31 | 2008-12-31 |
Training of Juan Andres
| Universida de Alcalá de Henares | Graduate Degree |
Statistics
International
| United States | 6 |
| Switzerland | 2 |
| Spain | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NOVARTIS AG | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| AVANTOR, INC. | Process Industries |
| MODERNA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Juan Andres
- Experience